Looking Back, Looking Forward at Halogen Bonding in Drug Discovery
Halogen bonding has emerged at the forefront of advances in improving ligand: receptor interactions. In particular the newfound ability of this extant non-covalent-bonding phenomena has revolutionized computational approaches to drug discovery while simultaneously reenergizing synthetic approaches t...
Main Authors: | Lois Mendez, Gabriela Henriquez, Suman Sirimulla, Mahesh Narayan |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2017-08-01
|
Series: | Molecules |
Subjects: | |
Online Access: | https://www.mdpi.com/1420-3049/22/9/1397 |
Similar Items
-
Preorganization: A Powerful Tool in Intermolecular Halogen Bonding in Solution
by: Martin H. H. Voelkel, et al.
Published: (2020-02-01) -
Design and Synthesis of a Chiral Halogen-Bond Donor with a Sp<sup>3</sup>-Hybridized Carbon–Iodine Moiety in a Chiral Fluorobissulfonyl Scaffold
by: Hiroto Uno, et al.
Published: (2020-10-01) -
Chalcogen Bonding in Co-Crystals: Activation through 1,4-Perfluorophenylene vs. 4,4′-Perfluorobiphenylene Cores
by: Arun Dhaka, et al.
Published: (2021-07-01) -
Does Chlorine in CH<sub>3</sub>Cl Behave as a Genuine Halogen Bond Donor?
by: Pradeep R. Varadwaj, et al.
Published: (2020-02-01) -
The Influence of Halogenated Hypercarbon on Crystal Packing in the Series of 1-Ph-2-X-1,2-dicarba-<i>closo</i>-dodecaboranes (X = F, Cl, Br, I)
by: Miroslav Havránek, et al.
Published: (2020-03-01)